Diabetes

Researchers have developed an ultrafast-acting form of insulin that promises to work up to four times faster than current formulations. The novel drug has only been tested in animals so far but the researchers hope to test it in human trials soon.

New results from a clinical trial evaluating the efficacy of diet and exercise as a front-line type 2 diabetes treatment reveal nearly two-thirds of patients achieved complete disease remission after just 12 months of lifestyle interventions.

Scientists at the University of Utah have borrowed useful elements of cone snail venom to produce a potent hybrid “mini-insulin” that acts far more swiftly, and could make treating diabetes far more effective as a result.

Imagine a device that lets people with diabetes use an app to give themselves a boost of insulin when they need it, without an injection. A prototype device can do just that, using electricity to control gene expression in encapsulated beta cells.

An international team of scientists has developed technology that could detect diabetes-induced blindness in its early stages, using a smartphone as the basis for a low-cost diagnostic method that could greatly improve care in developing regions.

A new experimental drug could help mitigate some of the dangerous side effects caused by a once-promising diabetes medication. Animal tests suggest the combination treatment is both safe and effective at helping regulate blood sugar levels in diabetics.

Researchers have developed a novel technique that combines two diabetes drugs into a single injection. Previously these compounds required separate injections, creating a barrier for treatment that led to few diabetics embracing the novel therapy.

In a new study led by the University of Verona, researchers have used plant viruses to make new nanoparticles that show promise in mice for treating autoimmune diseases like type 1 diabetes and rheumatoid arthritis.

Scientists exploring new treatments for obesity have found that implanting virus particles gleaned from the feces of lean mice into mice on a high-fat diet curtailed weight gain and progression of a precursor of type 2 diabetes.

Washington University scientists working on techniques to turn stem cells into pancreatic beta cells are now reporting another exciting breakthrough, combining them with the CRISPR gene-editing tool to reverse the disease in mice.

Scientists at MIT have developed a new type of implantable cell that could handle the heavy lifting for diabetics by overcoming rejection by the host’s immune system to go on producing insulin from within the body.

Triglycerides are a form of fat that circulates through the bloodstream, and high levels can lead to obesity and related illnesses. Now, researchers have found a way to efficiently produce a protein that clears these fats from the bloodstream.